Patellar Tendinopathy (Jumper's Knee, Investigational)
Investigational adjunct for chronic patellar tendinopathy (Blazina stage II-III); eccentric loading and heavy slow resistance training remain primary.
Краткая информация для пациента
- Есть ли FDA-допуск для этого показания?
- Not FDA-cleared for patellar tendinopathy. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- Какие доказательства существуют?
- Tier C (investigational). There are no published controlled trials. Patellar tendinopathy (jumper's knee) responds best to load management plus a progressive eccentric or heavy slow-resistance training program over 12+ weeks (the strongest RCT support for any tendinopathy). Adjunctive options with some evidence include extracorporeal shock-wave therapy (ESWT), PRP injection, and (for refractory cases) ultrasound-guided needling or surgical excision of degenerative tissue. Corticosteroid injection is generally avoided in patellar tendinopathy because of rupture risk.
- Основные риски
- Bleeding from each bite site for 6 to 24 hours after detachment
- Bruising over the anterior knee for 5 to 10 days
- Local skin or, rarely, Aeromonas hydrophila infection
- Allergic reaction to leech saliva (uncommon)
- Risk if placed too close to the patellar tendon itself - direct trauma may precipitate rupture
- Septic prepatellar bursitis if a contaminated bite penetrates near the prepatellar bursa
- Delay of evidence-based heavy slow-resistance training - the highest-evidence intervention
- Кому не следует это рассматривать
- Patients with suspected partial or complete patellar tendon rupture (surgical evaluation)
- Patients with patellofemoral pain syndrome, plica syndrome, or fat pad impingement misdiagnosed as tendinopathy
- Patients with recent corticosteroid injection at the site (within 4 weeks)
- Patients who have not completed at least 12 weeks of progressive eccentric or heavy slow-resistance training
- Patients on anticoagulants, with hemophilia, or with severe anemia
- Patients in active high-load training without scheduled rest
- Patients with active dermatitis or broken skin over the anterior knee
- О чём спросить врача
- Have I had ultrasound or MRI to characterize the tendon and rule out partial or complete tear?
- Have we ruled out patellofemoral pain, plica syndrome, or fat pad impingement as alternatives?
- Have I completed a structured 12-week progressive eccentric or heavy slow-resistance training program?
- Have I tried ESWT or PRP, and what is their evidence vs. this investigational option?
- Where exactly will leeches be placed - confirm placement is adjacent to (NOT directly on) the patellar tendon?
- What is the practitioner's plan if symptoms do not improve after 2 to 3 sessions?
- What is the Aeromonas-prevention protocol?
- Когда срочно обратиться за медицинской помощью
- Sudden pop, severe pain, and inability to extend the knee (possible patellar tendon rupture - surgical emergency)
- Acute severe knee swelling with warmth (possible septic bursitis or hemarthrosis)
- Sudden patella migration upward (suggests tendon rupture)
- Calf swelling, redness, or warmth (possible DVT)
- Bleeding from a bite site lasting more than 24 hours
- Fever, chills, or spreading redness at the bite site
- Hives, facial or throat swelling, or breathing difficulty
Что это НЕ означает
- This is not FDA-cleared for patellar tendinopathy.
- No controlled trials support efficacy; placebo response is high in chronic tendinopathy.
- It does not replace heavy slow-resistance training, which has the strongest RCT support.
- It does not address partial or complete tendon rupture, which is a surgical emergency.
- Direct trauma to the tendon may precipitate rupture - placement must be adjacent, not over the tendon.
Перекрёстные ссылки безопасности
Clinical Profile
- Category
- musculoskeletal
- ICD-10
- M76.50
- Safety tier
- medium
Evidence Summary
Patellar tendinopathy (jumper's knee) is a chronic insertional or mid-tendon degenerative process most common in jumping athletes. Evidence-based management is single-leg decline eccentric squat protocols, heavy slow resistance training, and selective extracorporeal shock-wave therapy. PRP injection has mixed evidence. No controlled clinical trial of peri-tendinous hirudotherapy for patellar tendinopathy has been published; any use is investigational and mechanistic only. Hirudotherapy as a primary intervention is inappropriate, and exercise rehabilitation must continue throughout.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Michalsen A (2007)0
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Tendon partial or complete tear (MRI confirmation needed)
- Osgood-Schlatter or Sinding-Larsen-Johansson disease (skeletally immature)
- Patellofemoral instability or maltracking as primary diagnosis
- Discontinuation of rehabilitation program
Related Conditions
Knee Osteoarthritis
Off-label use with three RCTs showing pain and function improvement comparable to NSAID gel at 3 months in mild-to-moderate symptomatic knee OA.
Thumb Carpometacarpal (CMC-1) Osteoarthritis
Off-label use with RCT evidence: single-session leech therapy reduces pain and improves function in CMC-1 (basal thumb) OA at 8 weeks.
Lateral Epicondylitis (Tennis Elbow)
Off-label use with two RCTs showing significant pain reduction at 7-12 weeks compared to topical NSAID and conventional physiotherapy.
Plantar Fasciitis
Off-label use with one RCT showing significant heel pain reduction at 6 weeks compared to conservative care.